ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Healthcare Shares
2 of the top ASX healthcare shares to own right now
Share Gainers
Here are the top 10 ASX 200 shares today
Healthcare Shares
Big ASX news: ResMed shares rocket 5% to new high
Healthcare Shares
With a 6% yield, is this the best ASX healthcare share to buy for dividends?
Blue Chip Shares
Buy ResMed and these top ASX 200 blue chip shares
Best Shares
Top ASX shares to buy now following stellar earnings results
Investing Strategies
2 soaring ASX 200 stocks to buy now
Broker Notes
3 must-own ASX shares to buy now
52-Week Highs
GYG and these 12 ASX 200 shares just hit new 52-week highs!
Healthcare Shares
What's happening with the ResMed share price today?
Healthcare Shares
Why are ASX healthcare shares dragging on the ASX 200 today?
Share Market News
Resmed, Telstra and Sayona Mining among the ASX shares investors bought most in FY24
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
